(Prasterone)
Medfinder tracks down Intrarosa for you. We keep calling pharmacies near you until one confirms your dose is in stock, then text you the details. Most patients are matched within 24 hours. Our real-time Intrarosa availability data is below.
Intrarosa is not currently listed on the FDA drug shortage list. Medfinder's availability score is 0% (Very Difficult to Find), based on 75 pharmacy checks in the last 30 days. 19 patients have searched for Intrarosa in the last 30 days. Last verified November 6, 2026, 7:00 AM ET.
Generated by Medfinder AI using proprietary data alongside publicly available data from the FDA and other sources.
Availability Score
Percentage of Medfinder pharmacy checks over the last 30 days that found this drug in stock. Calculated as in-stock reports ÷ total reports.0%(Very Difficult to Find)
FDA Status
Not ListedCurrent public availability signals for Intrarosa, recomputed every 6 hours from Medfinder pharmacy checks and FDA shortage records.
| Last verified | |
|---|---|
| Refresh cadence | Every 6 hours |
| Reporting window | Last 30 days |
| FDA status | Not listed |
| Availability score | 0% (Very Difficult to Find) |
| Pharmacy checks | 75 checks in the last 30 days |
| Patient reports | 19 |
| In-stock rate | 0% |
| Last in-stock report | No recent in-stock report |
| Methodology | How Medfinder verifies shortage and availability data |
Patient Shortage Reports
19
Total Pharmacies Checked
75
In Stock Percentage
0%
Total patient shortage reports for this medication over the last 8 weeks.
| Dosage | Total Pharmacies Checked | Change | Last Located | In Stock Percentage |
|---|---|---|---|---|
Get access to real-time availability data by region, pharmacy, and dosage — updated daily from thousands of pharmacy checks.
Summarized by Medfinder AI
FDA Status
N/AStart Date
N/AGet a weekly email with the latest drug shortage updates, resolutions, and availability changes.
We have a 99% success rate finding medications, even during nationwide shortages. Let us do the searching for you.
